December 19, 2016

Critical Outcome Technologies Reports Second Quarter Financial and Operating Results for Fiscal 2017

December 8, 2016

Critical Outcome Technologies Appoints Alison Silva as Chief Executive Officer

October 17, 2016

Critical Outcome Technologies Awards Stock Options

October 14, 2016

Critical Outcome Technologies Provides Update on Recent Achievements and Future Strategic Objectives at Annual General Meeting

October 11, 2016

Critical Outcome Technologies Announces Next Clinical Candidate, COTI-219, Targeting KRAS

September 29, 2016

Critical Outcome Technologies Reports Fiscal 2017 First Quarter Financial and Operating Results

September 13, 2016

Critical Outcome Appoints Dr. Bharatt Chowrira to its Board of Directors

August 23, 2016

Critical Outcome Technologies Announces the Opening of its U.S. Headquarters

August 3, 2016

Critical Outcome Technologies Reports Year-End Financial & Operating Results

July 12, 2016

Critical Outcome Initiates Third Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers

July 6, 2016

Critical Outcome Technologies Awards Stock Options

June 15, 2016

Critical Outcome Technologies Appoints Experienced Industry Executive as New President

June 8, 2016

Critical Outcome Announces No Material Change

June 6, 2016

Critical Outcome Activates Second Clinical Trial Site for its COTI-2 Gynecological Cancer Study

June 3, 2016

Critical Outcome Technologies Receives $1.6M from Warrant Exercises

June 1, 2016

Critical Outcome to Present at International Li-Fraumeni Syndrome Conference and at BIO International Convention

May 24, 2016

Critical Outcome Receives Additional Patent for Potential Transformational P53 Cancer Treatment

May 2, 2016

Critical Outcome Technologies Announces Additional Funding Through Warrant Exercises

April 27, 2016

Critical Outcome Technologies Augments Advisory Board Drug Development Experience

April 19, 2016

Critical Outcome Commences Treatment of Second Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers

March 30, 2016

Critical Outcome Technologies Completes Private Placement With A Successful U.S. Life Science Investor

March 22, 2016

Critical Outcome Technologies Provides Market Update

March 17, 2016

Critical Outcome Announces Funding Received Through Warrant Exercises

March 14, 2016

Critical Outcome Launches ROSALIND Precision Medicine Platform

March 11, 2016

Critical Outcome Technologies Reports Fiscal 2016 Third Quarter Financial and Operating Results

February 16, 2016

Critical Outcome Treats First Patient in Phase 1 Study of COTI-2 in Gynecologic Cancer

January 8, 2016

Critical Outcome Technologies Awards Stock Options